Evidence map›Paper›PMID 31131995›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2019

Regulation of Fatty Acid Oxidation by Twist 1 in the Metabolic Adaptation of T Helper Lymphocytes to Chronic Inflammation.

Kristyna Hradilkova, Patrick Maschmeyer, Kerstin Westendorf, Heidi Schliemann, Olena Husak, Anne Sae Lim von Stuckrad, Tilmann Kallinich, Kirsten Minden, Pawel Durek, Joachim R Grün and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Roles of Twist1 in lipid and glucose metabolism.Cell communication and signaling : CCS · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Obesity Inhibits Angiogenesis Through TWIST1-SLIT2 Signaling.Frontiers in cell and developmental biology · 2021
    Article
  10. Article
  11. Twist1: A Double-Edged Sword in Kidney Diseases.Kidney diseases (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kristyna HradilkovaDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Patrick MaschmeyerDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Kerstin WestendorfDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Heidi SchliemannDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Olena HusakDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Anne Sae Lim von StuckradCharité-Universitätsmedizin Berlin, Berlin, Germany.
Tilmann KallinichCharité-Universitätsmedizin Berlin, Berlin, Germany.
Kirsten MindenDeutsches Rheuma-Forschungszentrum Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pawel DurekDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Joachim R GrünDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Hyun-Dong ChangDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Andreas RadbruchDeutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
German Rheumatism Research Centre · DECharité - Universitätsmedizin Berlin · DE

Funding

BSRT graduate schoolDeutsche Forschungsgemeinschaft SFB650European Union FP7-PEOPLE-2011-ITN-289903EUTRAINFP7 Ideas: European Research Council 268987Horizon 2020 Framework Programme 777357Leibniz-GemeinschaftRheumastiftung
6 · The paper itself

Abstract

objectiveInflamed tissue is characterized by low availability of oxygen and nutrients. Yet CD4+ T helper lymphocytes persist over time in such tissue and probably contribute to the chronicity of inflammation. This study was undertaken to analyze the metabolic adaptation of these cells to the inflamed environment.

methodsSynovial and blood CD4+ T cells isolated ex vivo from patients with juvenile idiopathic arthritis (JIA) and murine CD4+ T cells were either stimulated once or stimulated repeatedly. Their dependency on particular metabolic pathways for survival was then analyzed using pharmacologic inhibitors. The role of the transcription factor Twist 1 was investigated by determining lactate production and oxygen consumption in Twist1-sufficient and Twist1-deficient murine T cells. The dependency of these murine cells on particular metabolic pathways was analyzed using pharmacologic inhibitors.

resultsProgrammed death 1 (PD-1)+ T helper cells in synovial fluid samples from patients with JIA survived via fatty acid oxidation (mean ± SEM survival of 3.4 ± 2.85% in the presence of etomoxir versus 60 ± 7.08% in the absence of etomoxir on day 4 of culture) (P < 0.0002; n = 6) and expressed the E-box-binding transcription factor TWIST1 (2-14-fold increased expression) (P = 0.0156 versus PD-1- T helper cells; n = 6). Repeatedly restimulated murine T helper cells, which expressed Twist1 as well, needed Twist1 to survive via fatty acid oxidation. In addition, Twist1 protected the cells against reactive oxygen species.

conclusionOur findings indicate that TWIST1 is a master regulator of metabolic adaptation of T helper cells to chronic inflammation and a target for their selective therapeutic elimination.

Indexed as

AnimalsArthritis, JuvenileCell SurvivalEnergy MetabolismFatty AcidsGlycolysisHumansInflammationLactic AcidMiceNuclear ProteinsOxidation-ReductionOxygen ConsumptionProgrammed Cell Death 1 ReceptorReactive Oxygen SpeciesSynovial FluidFatty AcidsLactic AcidNuclear ProteinsProgrammed Cell Death 1 ReceptorReactive Oxygen SpeciesTWIST1 protein, humanTwist1 protein, mouseTwist-Related Protein 1

Identifiers

PMID31131995
PMCPMC6790942
OpenAlexW2947583590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.